Insulin Glulisine
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Insulin Glulisine is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3 million on Insulin Glulisine across 10,000 claims for 3,190 beneficiaries.
Insulin Glulisine is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.16 to $10.50 per ML — a 29% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.16 – $10.50
per ML
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sanofi-Aventis U.S. LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLULISINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
APIDRA SOLOSTAR 100 UNIT/ML | $10.5010 per ML | -0.07% |
APIDRA 100 UNIT/ML VIAL | $8.1623 per ML | +0.02% |
Frequently Asked Questions
What is Insulin Glulisine used to treat?
Insulin Glulisine is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Glulisine?
In 2024, Medicare Part D spent $3 million on Insulin Glulisine across 10,000 claims for 3,190 beneficiaries.
How many Insulin Glulisine products are on the market?
The Insulin Glulisine drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Insulin Glulisine?
NADAC reference prices for Insulin Glulisine range from $8.1623 to $10.5010 per ML — a 29% difference between cheapest and most expensive.
Which manufacturers make Insulin Glulisine?
1 manufacturer lists Insulin Glulisine in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2).
How has the price of Insulin Glulisine changed recently?
Over the past 7 days, 1 Insulin Glulisine NDC rose and 1 fell, with a market-wide average change of -0.0%.